1. Market Research
  2. > Biotechnology Market Trends
  3. > Funding Patterns in the Global Pharma and Biotech Industry

Funding Patterns in the Global Pharma and Biotech Industry

  • April 2015
  • -
  • Frost & Sullivan
  • -
  • 57 pages

Increase in Exit Market Will Drive Investor Confidence

This research service analyzes the various PEVC and merger and acquisition deals in the pharmaceuticals and biotechnology industry. The deals are analyzed based on their number and average value. Trends are also observed based on the geographic region and buyer types. The study delves into the nature of cross-border deals and takes into account various deal multiples such as enterprise value, percent sought, and stock premium rise of the target company.

Executive Summary

Key Trends in the Pharma and Biotech Industry
- Pharma and biotech industry stock market indices have outperformed those of other industries in the study period.
- Profitability is reducing in large pharmaceuticals companies.
- Patent expiry and revenue loss in pharma and biotech companies.
- Government efforts to contain drug prices.
- Increasing market demand for drugs.
- Declining research & development (R&D) by large pharma companies.

Key Findings
- The pharma and biotech industry witnessed a decline in the volume of both private equity (PE) and venture capital (VC) deals. This is in tune with the overall decline in deals in healthcare in the study period.
- The PE deal volume in the pharmaceuticals sector declined steadily during 2010–2014, while the biotechnology sector witnessed an increase in deal volume during 2010–2013 and a slight decline in 2014.
- The initial public offering (IPO) market for the pharma and biotech industry has experienced steady growth post-2012.
- Depleting pipeline and increased cost pressures have made mergers and acquisitions (M&As) a lifeline for strategic growth for leading participants of the pharmaceuticals sector.

Table Of Contents

Funding Patterns in the Global Pharma and Biotech Industry
1. EXECUTIVE SUMMARY

Executive Summary

2. KEY TERMS USED IN THE STUDY

Key Terms Used in the Study

3. INTRODUCTION

Introduction
Research Objectives and Scope
Research Methodology

4. KEY TRENDS IN THE PHARMA AND BIOTECH INDUSTRY

Key Trends in the Pharma and Biotech Industry
Pharma and Biotech Industry—Stock Indices Performance
Pharma and Biotech Industry—Reducing Profitability
Pharma and Biotech Industry—Patent Expiry and Revenue Loss
Pharma and Biotech Industry—Efforts to Contain Prices
Pharma and Biotech Industry—Increasing Market Demand
Pharma and Biotech Industry—Declining RandD

5. KEY PEVC STATISTICS

Key PEVC Statistics
PEVC Deal Trends by Volume and Value
Volume and Value of PE Deal by Sector

6. VC DEAL—KEY METRICS

VC Deal—Key Metrics
VC Deal Trends by Sector
Pharmaceuticals Sector—Snapshot of VC Investment Stages
Biotechnology Sector—Snapshot of VC Investment Stages

7. PEVC GEOGRAPHIC ANALYSIS

PEVC Geographic Analysis
PEVC Deal Analysis in the North American Region
PEVC Deal Analysis in the European Region
PEVC Deal Analysis in the APAC Region

8. EXIT TRANSACTION ANALYSIS

Exit Transaction Analysis
PEVC Exits Through IPO
PEVC Exits through MandA

9. MandA TRANSACTIONS

MandA Transactions
Pharmaceuticals Sector—MandA Analysis
Biotechnology Sector—MandA Analysis

10. GEOGRAPHIC ANALYSIS OF MandA DEALS

Geographic Analysis of MandA Deals
MandA Deal Volume Analysis across Geographies
MandA Deal Value Share Analysis across Geographies

11. CROSS-BORDER DEAL ANALYSIS—BUYER'S PERSPECTIVE FOR ASIA-PACIFIC, EUROPE, AND NORTH AMERICA

Cross-border Deal Analysis—Buyer's Perspective for Asia-Pacific, Europe, and North America
MandA Trends of Cross-border Deals—Asia-Pacific Buyers
MandA Trends of Cross-border Deals—European Buyers
MandA Trends of Cross-border Deals—North American Buyers

12. TYPE OF INTEGRATION

Type of Integration
MandA Trends in the Pharmaceuticals Sector by Type of Integration
MandA Trends in the Biotechnology Sector by Type of Integration

13. CONCLUSIONS

Conclusions
Four Big Conclusions
Legal Disclaimer

14. THE FROST and SULLIVAN STORY

The Frost and Sullivan Story
Value Proposition—Future of Your Company and Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Bioreactors Market by Scale Range, Material, Usage, Suppliers, End-User, Region - Global Forecast to 2021

Bioreactors Market by Scale Range, Material, Usage, Suppliers, End-User, Region - Global Forecast to 2021

  • $ 18000
  • Industry report
  • September 2016
  • by MarketsandMarkets

The global bioreactors market is expected to reach to USD 1,417 million by 2021 from USD 955 million in 2015, at a CAGR of 6.8% between 2015 and 2021.The increase in adoption of single-use technologies, ...

Single-use Bioreactor Market by Product, Cell, Technology, Application, End User - Global Forecast to 2021

Single-use Bioreactor Market by Product, Cell, Technology, Application, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global single-use bioreactors market is projected to reach USD 1,085.7 million by 2021 from USD 408.4 million in 2016, growing at a CAGR of 21.6% during the forecast period (2016–2021). In this report, ...

Tangential Flow Filtration Market Product, Membrane Material, Technology, Pore Size, Application Global Forecast to 2021

Tangential Flow Filtration Market Product, Membrane Material, Technology, Pore Size, Application Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The tangential flow filtration market is projected to reach USD 1,005.0 million by 2021 USD 554.7 million in 2016, growing at a CAGR of 12.6% during the forecast period (2016–2021). Growth in the bi ...


Download Unlimited Documents from Trusted Public Sources

Genetic Industry in Denmark and Brazil

  • November 2016
    9 pages
  • Genetic  

  • Denmark  

    Brazil  

View report >

Global Tissue Engineering Markets

  • November 2016
    34 pages
  • Tissue Engineer...  

    Cell Therapy  

    Skin Care  

  • United States  

    World  

View report >

Global Nanomedicine Industry - Forecast

  • November 2016
    23 pages
  • Nanomedicine  

    Personal Genomi...  

    Gene Therapy  

  • United States  

    World  

    Japan  

View report >

Related Market Segments :

Biotech

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.